NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX)

CUSIP: 64125C109

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
99,963,154
Total 13F shares
84,777,416
Share change
-2,716,107
Total reported value
$3,856,100,900
Put/Call ratio
16%
Price per share
$45.45
Number of holders
225
Value change
-$118,084,536
Number of buys
105
Number of sells
115

Quarterly Holders Quick Answers

What is CUSIP 64125C109?
CUSIP 64125C109 identifies NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) as of Q2 2016

As of 30 Jun 2016, NEUROCRINE BIOSCIENCES INC - Common Stock, $0.001 par value (NBIX) was held by 225 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 84,777,416 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, BB BIOTECH AG, PERCEPTIVE ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, STATE STREET CORP, and ORBIMED ADVISORS LLC. This page lists 225 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.